NCT04356092

Brief Summary

A custom-made, 2D-perfusion digital subtraction angiography (PDSA) algorithm has been designed and implemented towards foot perfusion quantification following endovascular treatment of critical limb ischemia (CLI), in order to assist intra-procedural decision-making and enhance clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2020

Completed
Last Updated

April 22, 2020

Status Verified

April 1, 2020

Enrollment Period

2.2 years

First QC Date

April 15, 2020

Last Update Submit

April 18, 2020

Conditions

Keywords

Infrapopliteal angioplastyTissue perfusionQuantification

Outcome Measures

Primary Outcomes (3)

  • Change in Perfusion Blood Volume (PBV)

    PBV calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.

    Ten minutes before and five minutes after the intervention

  • Change in Mean Transit Time (MTT)

    MTT calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.

    Ten minutes before and five minutes after the intervention

  • Change in Perfusion Blood Flow (PBF)

    PBF calculated on subtraction images and pre- and post-procedural values compared using the proposed 2D perfusion DSA software.

    Ten minutes before and five minutes after the intervention

Secondary Outcomes (2)

  • Major amputation rate

    Six months

  • Procedure-related complications

    30 days

Study Arms (1)

Perfusion

EXPERIMENTAL

Consecutive patients scheduled to undergo infrapopliteal angioplasty or stenting, or both, as part of their standard treatment for Rutherford-Becker class 5 and 6 chronic limb-threatening ischemia, were included in the study. All procedures were performed using local anesthesia. An antegrade access was used in all patients followed by the deployment of a 5 or 6 Fr arterial sheaths. A semi-lateral foot projection was preferred and the pre-revascularization DSA of the foot was performed via a 5 Fr angiographic catheter placed at the distal third of the popliteal artery. Following revascularization of one or more tibial arteries, the catheter was placed at the same popliteal segment and post-procedural DSA of the foot was performed following the exact pre-revascularization injection protocol at the same semi-lateral projection. The 2D-perfusion imaging and analysis of the DICOM files was performed after revascularization.

Diagnostic Test: 2D perfusion digital subtraction angiography of the foot.

Interventions

2D perfusion digital subtraction angiography of the foot was performed after infrapopliteal angioplasty and Perfusion Blood Volume (PBV), Mean Transit Time (MTT), and Perfusion Blood Flow (PBF) maps were extracted by analyzing Time-Intensity Curves and signal intensity on the perfused vessel mask.

Also known as: Infrapopliteal angioplasty
Perfusion

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients prescheduled for infrapopliteal angioplasty due to chronic limb-threatening ischemia.
  • Written informed consent obtained

You may not qualify if:

  • Image post-processing not feasible due to significant motion artifacts produced during DSA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Patras University Hospital

Pátrai, Achaia, 26500, Greece

Location

Related Publications (1)

  • Kagadis GC, Tsantis S, Gatos I, Spiliopoulos S, Katsanos K, Karnabatidis D. 2D perfusion DSA with an open-source, semi-automated, color-coded software for the quantification of foot perfusion following infrapopliteal angioplasty: a feasibility study. Eur Radiol Exp. 2020 Sep 2;4(1):47. doi: 10.1186/s41747-020-00176-z.

Study Officials

  • Dimitris Karnamatidis, MD, PhD

    Patras University Hospital, Rion, Greece

    STUDY CHAIR
  • George Kagadis, PhD, FAAPM

    University of Patras, Greece

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
2D-perfusion imaging and analysis of the DICOM files was performed after revascularization, by an investigator blinded to the name of the patient or the result of the angioplasty procedure. The participant was also blinded to the results of the perfusion outcomes during follow up.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: In total, 7 consecutive patients were included in the study. The 2D-perfusion imaging and analysis of the DICOM files were performed after revascularization.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in Interventional Radiology

Study Record Dates

First Submitted

April 15, 2020

First Posted

April 22, 2020

Study Start

May 2, 2017

Primary Completion

July 14, 2019

Study Completion

July 14, 2019

Last Updated

April 22, 2020

Record last verified: 2020-04

Locations